2Maisel AS, McCullough PA. Cardiac natriuretic peptides: a proteomic window to cardiac fimction and clinical management[J]. Rev Cardiovasc Med,2003 ;4(suppl4) :3-12.
3Morrison LK,Harrison A,Krishnaswamy P,et al. Utility of a rapid B-type peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coll Cardiol, 2002 ; 39 : 202-9.
4Dao Q,Krishmaswamy P,Kazanegra R,et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgenteare setting[J]. J Am Coll Carol ,2001 ;37:379-85.
5Lubien E, Demaria A, Krishnaswamy P,et al. Utility of B-type natriureic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings[J]. Circulation ,2002 ; 105:595-601.
6Mukoyama M. Brain natriuretic peptide as a novel hormone in humans. Evidence for an exquisite dual natriuretic peptide system, artial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991 ; 87 : 1402-12.
7Selvais PL,Donckier JE, Robert A,et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure : influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation[J]. Eur J Clin Invest, 1998 ;28:636-42.
8Maisel AS,McCord J, Noeak RM,et al. Beside B-type natriureic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction[J]. J Am Coll Cardiol,2003 ;41:2010-7.
